RSS-Feed abonnieren
Bitte kopieren Sie die angezeigte URL und fügen sie dann in Ihren RSS-Reader ein.
https://www.thieme-connect.de/rss/thieme/de/10.1055-s-00035024.xml
Thromb Haemost 2001; 85(04): 743
DOI: 10.1055/s-0037-1615662
DOI: 10.1055/s-0037-1615662
Letters to the Editor
The Blue Toe Syndrome during Oral Anticoagulant Therapy with Acenocoumarol
Weitere Informationen
Publikationsverlauf
Received
21. September 2001
Accepted after revision
30. November 2000
Publikationsdatum:
08. Dezember 2017 (online)
![](https://www.thieme-connect.de/media/10.1055-s-00035024/200104/lookinside/thumbnails/10-1055-s-0037-1615662-1.jpg)
-
References
- 1 Karmody AM, Powers SR, Monaco VJ, Leather RP. “Blue toe” syndrome: an indication for limb salvage surgery. Arch Surg 1976; 111: 1263-8.
- 2 Feder W, Auerbach R. “Purple toes”: an uncommon sequela of oral coumarin drug therapy. Ann Intern Med 1961; 55: 91-7.
- 3 O’Keeffe ST, Woods BO, Breslin DJ, Tsapatsaris NP. Blue toe syndrome. Arch Intern Med 1992; 152: 2197-202.
- 4 Sallah S, Thomas DP, Robers HR. Warfarin and Heparin-Induced Skin Necrosis and the Purple Toe Sydrome: Infrequent Complications of Anticoagulant Treatment. Thromb Haemost 1997; 78: 785-90.
- 5 Brewer ML, Kinnison ML, Perler BA, White RI. Blue Toe Syndrome: Treatment with Anticoagulants and Delayed Percutaneous Transluminal Angioplasty. Radiology 1988; 166: 31-6.